1. Weidner W, Schiefer HG, Krauss H et al. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991; 19 (Suppl. 3): 119–25.
2. Krieger JN, Nyberg LJr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282: 236–7.
3. Krieger JN, Ross SO, Penson DF, Riley DE. Symptoms and inflammation in chronic prostatitis/chronic pelvic pain syndrome. Urology 2002; 60: 959–63.
4. de la Rosette JJ, Hubregtse MR, Meuleman EJ et al. Diagnosis and treatment of 409 patients with prostatitis syndrome. Urology 1993; 41: 301–7.
5. Krieger JN, Riley DE, Cheah PY et al. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol 2003; 21: 70–4.
6. Krieger JN, Ross SO, Riley DE. Chronic prostatitis: epidemiology and role of infection. Urology 2002; 60 (6 Suppl.): 8–12; discussion 13.
7. Potts JM. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164: 1550–3.
8. True LD, Berger RE, Rothman I et al. Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol 1999; 162: 2014–8.
9. Schaeffer AJ, Knauss JS, Landis JR et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol 2002; 168: 1048–53.
10. Nickel JC, Alexander RB, Schaeffer AJ et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol 2003; 170: 818–22.
11. Nickel JC, Downey J, Clark J et al. Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebocontrolled multicenter trial. Urology 2003; 62: 614–7.
12. Alexander RB, Propert KJ, Schaeffer AJ et al. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 2004; 141: 581–9.
13. Nickel JC, Downey J, Ardern D et al. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 2004; 172: 551–4.
14. Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol 2006; 176 (4 Pt 1): 1534–8.
15. Schneider H, Wilbrandt K, Ludwig M et al. Prostate-related pain in patients with chronic prostatitis/chronic pelvic pain syndrome. BJU Int 2005; 95 (2): 238–43.
16. Wesselmann U, Burnett AL, Heinbe LJ. The urogenital and rectal pain syndromes. Pain 1997; 73: 269.
17. Meares EM, Stamey TA. Bacteriological localization pattems in bacteral proslatilis and urethritis. Invest Urol 1968; 5: 492.
18. Nickel JC. The pre and post massage test (PPMT): a simple screen for prostatitis. Tech Urol 1997; 3: 38–43.
19. Alexander RB. Evaluation of the patient. In: Textbook of prostatitis, p. 179–86. Ed: Nickel JC, Isis Medical Media, Oxford, 1999.
20. Nickel JC, Ardern D and Downey J. Cytologic evaluation of urine is important in evaluation of chronic prostatitis. Urology 2002; 60: 225–7.
21. Zermann D-H, Ishigooka M, Doggweiler R, Schmidt RA. Chronic prostatitis: a myofascial pain syndrome? Infect Urol 1999; 12: 84–92.
22. Berger RE, Ciol MA, Rothman I, Turner JA. Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol 2007; 7: 17.
23. Kaplan SA, Ikeguchi EF, Santarosa RP et al. Etiology of voiding dysfunction in men less than 50 years of age. Urology 1996; 47: 836–9.
24. Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. Urol 1999; 162: 369–75.
25. Turner JA, Ciol MA, von Korff M, Berger R. Validity and responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol 2003; 169: 580–3.
26. Nickel JC. Prostatitis: evolving management strategies. Urol Clin North Am 1999; 26 (4): 737–51.
27. Fall M, Baranowski AP, Fowler CJ et al. Guidelines on Chronic Pelvic Pain. Eur Assoc Urol 2007.
28. Mishra VC, Browne J, Emberton M. Role of alpha-blockers in type III prostatitis: a systematic review of the literature. J Urol 2007; 177: 25–30.
29. Potts JM, Moritz N, Everson D et al. Chronic abacterial prostatitis: a functional somatic syndrome? [abstract] Presented at: Annual Meeting of the American Urological Association; June 2, 2001; Anaheim, CA. Abstract 2005126.
30. Bass C, May S. Chronic multiple functional somatic symptoms. BMJ 2002; 325: 323–6.
31. Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol 2005; 174: 155–60.
32. Zermann DH, Ishigooka M, Schubert J et al. Periprostatic injection of botulinum toxin type A. Eur Urol 2000; 38: 393–9.

Е.Б.Мазо, М.Е.Школьников